It would mean having to end our preclinical studies and our clinical trials.
On December 5th, 2022. See this statement in context.
On December 5th, 2022. See this statement in context.
December 5th, 2022 / 8:30 p.m.
President and Chief Executive Officer, BioCanRx
It would mean having to end our preclinical studies and our clinical trials.
See context to find out what was said next.